IDEAYA Biosciences, Inc.
IDYA
$23.63
-$0.49-2.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 692.51M | 676.32M | 920.03M | 701.66M | 698.77M |
| Total Receivables | -- | 3.00K | 20.00K | 1.00K | 15.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.36M | 13.39M | 12.17M | 11.52M | 10.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 707.87M | 689.71M | 932.21M | 713.18M | 709.35M |
|
|
|||||
| Total Current Assets | 707.87M | 689.71M | 932.21M | 713.18M | 709.35M |
| Net Property, Plant & Equipment | 33.30M | 27.74M | 26.62M | 8.43M | 8.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 805.00K | 805.00K | 911.00K | 986.00K | 849.00K |
| Total Assets | 1.10B | 1.12B | 1.24B | 973.66M | 961.53M |
|
|
|||||
| Total Accounts Payable | 17.63M | 15.42M | 12.57M | 15.89M | 6.29M |
| Total Accrued Expenses | 32.91M | 30.35M | 28.09M | 24.25M | 17.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 308.00K | 298.00K | -- | 606.00K | 1.15M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 50.85M | 46.07M | 40.66M | 40.74M | 24.96M |
|
|
|||||
| Total Current Liabilities | 50.85M | 46.07M | 40.66M | 40.74M | 24.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.66M | 18.87M | 18.80M | 1.26M | 1.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 76.51M | 64.94M | 59.46M | 42.01M | 26.22M |
|
|
|||||
| Common Stock & APIC | 1.72B | 1.68B | 1.67B | 1.37B | 1.32B |
| Retained Earnings | -695.02M | -622.84M | -492.53M | -440.71M | -387.94M |
| Treasury Stock & Other | 1.59M | 812.00K | 3.84M | -1.42M | -923.00K |
| Total Common Equity | 1.02B | 1.06B | 1.18B | 931.66M | 935.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.02B | 1.06B | 1.18B | 931.66M | 935.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.02B | 1.06B | 1.18B | 931.66M | 935.31M |
|
|
|||||